MSKCC

Though researchers highlighted their goal of using the method to move toward a test to detect early cancers, their current data speaks only to the method's performance in late-stage cancer patients.

Researchers hope to identify exosomal biomarkers that can predict or detect cancer recurrence and metastasis at its earliest stages.

Scientists at Memorial Sloan Kettering Cancer Center, led by Gabriela Chiosis, revealed how the complexes are important for tumor survival in certain cases.

The partners said they will use genetic sequencing and a combination therapy to determine predictors of sustained minimal residual disease negativity.

In a cohort of more than 150 patients, none who responded well to anti-androgen therapy had AR-V7-positive circulating tumor cells detected by Epic's technology.

Sage is handling the initial data processing and cleaning for the consortium, while MSKCC is providing infrastructure for hosting the data.

NEW YORK (GenomeWeb) -- Quest Diagnostics has launched a next-generation sequencing-based 34-gene panel called OncoVantage and plans to collaborate with Memorial Sloan-Kettering Cancer Center for clinical annotation of the test, Quest said this week.

SAN DIEGO (GenomeWeb News) — Reporting incidental or secondary findings may pose a challenge for the cancer field, a panel at this year's American Association for Cancer Research meeting said.

NEW YORK (GenomeWeb News) – A trio of papers in Nature Genetics describe findings from genomic studies of an ovarian cancer called small cell carcinoma of the ovary, hypercalcemic type, that implicate mutations in the SMARCA4 gene in the development of the disease.

NEW YORK (GenomeWeb News) – A pair of studies that appeared in Nature Genetics yesterday implicated mutations in the ESR1 gene in the development of hormone-resistant metastatic breast cancer.

Pages

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.